Literature DB >> 32741475

The Epidemiology of Pituitary Adenomas.

Adrian F Daly1, Albert Beckers2.   

Abstract

Pituitary adenomas are usually nonmalignant, but have a heavy burden on patients and health care systems. Increased availability of MRI has led to an increase in incidentally found pituitary lesions and clinically relevant pituitary adenomas. Epidemiologic studies show that pituitary adenomas are increasing in incidence (between 3.9 and 7.4 cases per 100,000 per year) and prevalence (76 to 116 cases per 100,000 population) in the general population (approximately 1 case per 1000 of the general population). Most new cases diagnosed are prolactinomas and nonsecreting pituitary adenomas. Most clinically relevant pituitary adenomas occur in females, but pituitary adenomas are clinically heterogeneous.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acromegaly; Cushing’s disease; Epidemiology; Incidence; Nonfunctioning pituitary adenoma; Pituitary adenoma; Prevalence; Prolactinoma

Mesh:

Year:  2020        PMID: 32741475     DOI: 10.1016/j.ecl.2020.04.002

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  23 in total

1.  Classifying Pituitary Adenoma Invasiveness Based on Radiological, Surgical and Histological Features: A Retrospective Assessment of 903 Cases.

Authors:  Liang Lu; Xueyan Wan; Yu Xu; Juan Chen; Kai Shu; Ting Lei
Journal:  J Clin Med       Date:  2022-04-27       Impact factor: 4.964

Review 2.  Epidemiology of Male Hypogonadism.

Authors:  Arthi Thirumalai; Bradley D Anawalt
Journal:  Endocrinol Metab Clin North Am       Date:  2022-02-08       Impact factor: 4.748

3.  Radiomics analysis allows for precise prediction of silent corticotroph adenoma among non-functioning pituitary adenomas.

Authors:  Wenting Rui; Nidan Qiao; Yao Zhao; Zhenwei Yao; Yue Wu; Yong Zhang; Ababikere Aili; Zhaoyun Zhang; Hongying Ye; Yongfei Wang
Journal:  Eur Radiol       Date:  2021-11-27       Impact factor: 7.034

Review 4.  Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification.

Authors:  Ashley B Grossman; Shereen Ezzat; Sylvia L Asa; Ozgur Mete; Michael D Cusimano; Ian E McCutcheon; Arie Perry; Shozo Yamada; Hiroshi Nishioka; Olivera Casar-Borota; Silvia Uccella; Stefano La Rosa
Journal:  Mod Pathol       Date:  2021-05-21       Impact factor: 7.842

5.  Editorial Comment: Radiomics analysis allows for precise prediction of silent corticotroph adenoma among non-functioning pituitary adenomas.

Authors:  Vincent Bourbonne
Journal:  Eur Radiol       Date:  2022-01-19       Impact factor: 5.315

Review 6.  How to Classify and Define Pituitary Tumors: Recent Advances and Current Controversies.

Authors:  Congxin Dai; Jun Kang; Xiaohai Liu; Yong Yao; Haijun Wang; Renzhi Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-17       Impact factor: 5.555

7.  Racial Disparities in Acromegaly and Cushing's Disease: A Referral Center Study in 241 Patients.

Authors:  Adriana G Ioachimescu; Neevedita Goswami; Talin Handa; Adlai Pappy; Emir Veledar; Nelson M Oyesiku
Journal:  J Endocr Soc       Date:  2021-11-24

Review 8.  Current and Emerging Medical Therapies in Pituitary Tumors.

Authors:  Nicolas Sahakian; Frédéric Castinetti; Thierry Brue; Thomas Cuny
Journal:  J Clin Med       Date:  2022-02-12       Impact factor: 4.241

9.  A novel human tumoroid 3D model of sustained ACTH-secreting cell cultures to study critically needed therapies for Cushing's disease.

Authors:  Antonio C Fuentes-Fayos; Raúl M Luque
Journal:  EBioMedicine       Date:  2021-05-13       Impact factor: 8.143

10.  Sellar Region Lesions and Intracranial Aneurysms in the Era of Endoscopic Endonasal Approach.

Authors:  Siyu Yan; Yifan Liu; Chang Liu; Li Yang; Yun Qin; Ran Liu; Shan Wang; Xue Li; Wenjie Yang; Lu Ma; Chao You; Liangxue Zhou; Rui Tian
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-04       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.